XML 27 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Inventories
9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Inventories Inventories
Inventories consisted of the following:
September 30
2023
December 31
2022
Long-term contracts in progress$237 $582 
Commercial aircraft programs68,551 67,702 
Capitalized precontract costs(1)
890 794 
Commercial spare parts, used aircraft, general stock materials and other
9,294 9,073 
Total$78,972 $78,151 
(1) Capitalized precontract costs at September 30, 2023 and December 31, 2022 includes amounts related to KC-46A Tanker, Commercial Crew, and T-7 Production Options. See Note 9.
Commercial Aircraft Programs
Commercial aircraft programs inventory included approximately 250 737 aircraft at September 30, 2023 and December 31, 2022, and approximately 75 and 100 787 aircraft at September 30, 2023 and December 31, 2022.
At September 30, 2023 and December 31, 2022, commercial aircraft programs inventory included the following amounts related to the 737 program: deferred production costs of $5,359 and $2,955 and unamortized tooling and other non-recurring costs of $574 and $626. At September 30, 2023, $5,899 of 737 deferred production costs, unamortized tooling and other non-recurring costs are expected to be recovered from units included in the program accounting quantity that have firm orders and $34 is expected to be recovered from units included in the program accounting quantity that represent expected future orders.
At September 30, 2023 and December 31, 2022, commercial aircraft programs inventory included the following amounts related to the 777X program: $1,370 and $1,330 of deferred production costs and $3,956 and $3,774 of unamortized tooling and other non-recurring costs. In April 2022, we decided to pause production of the 777X-9 during 2022 and 2023. The production pause is resulting in abnormal production costs that are being expensed as incurred until 777X-9 production resumes. We have been gradually restarting the 777X production system and expect all phases to resume during the fourth quarter of 2023. We expensed abnormal production costs of $442 and $213 during the nine months ended September 30, 2023 and 2022. The 777X program has near break-even margins at September 30, 2023.
At September 30, 2023 and December 31, 2022, commercial aircraft programs inventory included the following amounts related to the 787 program: deferred production costs of $12,188 and $12,689, $1,734 and $1,831 of supplier advances, and $1,531 and $1,722 of unamortized tooling and other non-recurring costs. At September 30, 2023, $13,024 of 787 deferred production costs, unamortized tooling and other non-recurring costs are expected to be recovered from units included in the program accounting quantity that have firm orders and $695 is expected to be recovered from units included in the program accounting quantity that represent expected future orders. We are currently producing at abnormally low rates resulting in abnormal production costs that are being expensed as incurred. We do not expect abnormal costs related to abnormally low production rates to continue beyond September 30, 2023, and we expect the remaining abnormal costs related to inspections and rework to be incurred by the end of 2024. We expensed abnormal production costs of $937 and $925 during the nine months ended September 30, 2023 and 2022.
Commercial aircraft programs inventory included amounts credited in cash or other consideration (early issue sales consideration) to airline customers totaling $3,862 and $3,586 at September 30, 2023 and December 31, 2022.